Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Idorsia

Explore full profile

The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients

Allschwil, SwitzerlandFounded 2017Biotech & Life Sciences
Valuation $2.55B Market cap · Aug/2026
Revenue $202M Latest reported FY

At a glance

Founded
2017
Headquarters
Allschwil, Switzerland
Listing
IPO 2017
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Employees mapped 632 incl. 7 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
18 countries with
team presence
🇨🇭 Switzerland61.9%
🇫🇷 France12.4%
🇺🇸 United States10.7%
🇬🇧 United Kingdom4%
🇩🇪 Germany3.6%
Top 5 of 18 shown
Web traffic by country
26K monthly visits
across markets
🇨🇭 Switzerland54.6%
🇬🇧 United Kingdom25.8%
🇺🇸 United States16.2%
🇨🇦 Canada12.3%
🇫🇷 France8.1%
Top 5 markets shown

Patents

Estimated portfolio value
$333M

167 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Idorsia on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Idorsia on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.